Page last updated: 2024-12-08
hemanthidine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
hemanthidine: crinine-like alkaloid from AMARYLLIDACEAE [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Amaryllidaceae | family | A family of herbaceous plants with bulbs or rhizomes in the order Asparagales.[MeSH] | Amaryllidaceae | A family of herbaceous plants with bulbs or rhizomes in the order Asparagales.[MeSH] |
Cross-References
ID Source | ID |
---|---|
PubMed CID | 544807 |
MeSH ID | M0223110 |
Synonyms (9)
Synonym |
---|
hemanthidine |
crinan-6,11-diol, 1,2-didehydro-3-methoxy-, (3beta,5alpha,6beta,11r,13beta,19alpha)- |
3h,6h-5,11b-ethano[1,3]dioxolo[4,5-j]phenanthridine, crinan-6,11-diol deriv. |
crinan-6,11-diol, 1,2-didehydro-3-methoxy-, (3.beta.,5.alpha.,6.beta.,11r,13.beta.,19.alpha.)- |
4a.beta.,5.alpha.,11b.alpha.-crinan-6.beta.,12-diol, 1,2-didehydro-3.beta.-methoxy-, (12r)- |
3-methoxy-1,2-didehydrocrinan-6,11-diol # |
crinan-7,18-diol, 1,2-didehydro-3-methoxy-, (3.beta.,5.beta.,6.alpha.,7.beta.,17.alpha.,18r)- |
ZSTPNQLNQBRLQF-UHFFFAOYSA-N |
15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.01,13.02,10.04,8]nonadeca-2,4(8),9,16-tetraene-11,18-diol |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.39
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.39) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |